ArticleJournal of biomedical science2016

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.

Fateme Gableh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.